Periodontal disease and preterm delivery of low-birth-weight infants

Tim McGaw1

  • 1Division of Oral Medicine and Pathology, Faculty of Medicine and Dentistry, University of Alberta, Edmonton, Alberta. tim.mcgaw@ualberta.ca

Insights

Periodontal disease may be linked to preterm delivery of low-birth-weight infants (PLBW). Further research is needed to confirm if periodontitis is a direct cause of PLBW.

Area of Science:

  • Obstetrics and Gynecology
  • Periodontology
  • Neonatal Health

Background:

  • Preterm delivery of low-birth-weight infants (PLBW) is a major public health concern, causing neonatal mortality and long-term health issues.
  • Epidemiological and immunological studies suggest a potential link between periodontal disease and PLBW.

Purpose of the Study:

  • To explore the potential role of periodontal disease as an independent risk factor for PLBW.
  • To examine proposed mechanisms linking periodontitis to adverse pregnancy outcomes.

Main Methods:

  • Review of epidemiological, microbiological, and immunological studies.
  • Discussion of postulated mechanisms, including pathogen translocation and inflammatory mediator action.
  • Consideration of non-causal explanations for the observed correlation.

Main Results:

  • Periodontal disease is suggested as a potential independent risk factor for PLBW.
  • Mechanisms involve pathogen or inflammatory mediator transfer from the oral cavity to the fetoplacental unit.
  • Non-causal associations between periodontitis and PLBW are also possible.

Conclusions:

  • The association between periodontitis and PLBW requires further investigation.
  • Prospective and interventional studies are necessary to establish causality.
  • Periodontitis is not yet confirmed as a causal factor for PLBW.

Related Concept Videos

Development of the Oral Microbiota01:28

Development of the Oral Microbiota

The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
The Oral Microbiota01:27

The Oral Microbiota

The oral microbiome includes a complex ecosystem comprising over 700 microbial species, identified through genomic sequencing and culture-based analyses to date. This community includes a core microbiome, found universally among individuals, and a variable component influenced by environmental factors such as diet, lifestyle, and host genetics. Site-specific conditions, including oxygen gradients, pH levels, and nutrient availability, determine the spatial distribution of these microorganisms...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...